Marcain Spinal Tung

Bupivacaine hydrochloride, the active ingredient in Marcain Spinal Tung, is a local anesthetic presented as a sterile solution for epidural and intrathecal use. It provides surgical anesthesia and analgesia for patients undergoing operative procedures, including obstetric, orthopedic, and general surgery.

GNH USA supplies Marcain Spinal Tung as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to European Union quality standards and ensures consistent product availability across global markets.

Bupivacaine hydrochloride is a local anesthetic used in spinal and epidural pathways to achieve regional anesthesia. - Surgical anesthesia: provides profound loss of sensation for operative procedures. - Epidural analgesia: delivers continuous pain relief during labor or postoperative recovery. - Spinal anesthesia: induces rapid, dense sensory block for lower‑body surgeries.

Bupivacaine may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Hypotension: transient drop in blood pressure after injection. - Bradycardia: slowed heart rate. - Nausea: feeling of sickness. - Pruritus: localized itching at the injection site. - Headache: mild to moderate tension‑type headache.

Serious or Rare Side Effects: - Cardiac arrhythmia: abnormal heart rhythm that can be life‑threatening. - Seizures: central nervous system excitation leading to convulsions. - Respiratory depression: reduced breathing effort. - Methemoglobinemia: abnormal hemoglobin affecting oxygen transport.

When using Marcain Spinal Tung, clinicians should observe several precautionary measures to minimize risk. - Patient assessment: evaluate cardiovascular and neurological status before administration. - Dose calculation: base dose on patient weight, age, and clinical setting. - Monitoring: continuously observe blood pressure, heart rate, and oxygen saturation during and after injection. - Allergic history: confirm no known hypersensitivity to amide‑type local anesthetics. - Drug interactions: avoid concurrent use with agents that may potentiate CNS or cardiac toxicity. - Store below 25°C: keep in original container, protect from light and moisture.

Bupivacaine can interact with other medications, influencing its safety profile.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): may enhance cardiotoxicity. - CNS depressants (e.g., benzodiazepines, barbiturates): increase risk of respiratory depression. - Lithium: potentiates neurotoxic effects.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may exacerbate bradycardia. - Calcium channel blockers: can augment hypotensive response. - MAO inhibitors: may alter plasma concentrations. - Epinephrine (when added): can increase systemic absorption and toxicity.